Literature DB >> 20935460

Early alterations of autophagy in Huntington disease-like mice.

Mary Y Heng1, Peter J Detloff, Henry L Paulson, Roger L Albin.   

Abstract

In a recent study, we reported in vivo evidence of early and sustained alterations of autophagy markers in a novel knock-in mouse model of Huntington disease (HD). The novel model is derived from selective breeding of HdhQ150 knock-in mice to generate mice with ~200 CAG/polyglutamine repeats (HdhQ200). HdhQ200 knockin mice exhibit an accelerated and more robust motor phenotype than the parent line with detectable abnormalities at 50 weeks and substantial impairments at 80 weeks. Heterozygous HdhQ200 knock-in mice accumulate htt aggregates as cytoplasmic aggregation foci (AF) as early as 9 weeks of age followed by striatal neuronal intranuclear inclusions (NIIs) by 20 weeks. By 40 weeks, striatal AF are perinuclear and immunoreactive for ubiquitin and the autophagosome marker LC3. Increased LC3-II protein expression is noted at 9 weeks and sustained throughout the disease course, and is paralleled by increased expression of p62. Early and sustained expression of: autophagy-related proteins in this genetically precise mouse model of HD suggests that alteration of autophagic flux is an important and early component of neuronal response to polyglutamine expanded huntingtin.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20935460      PMCID: PMC3039724          DOI: 10.4161/auto.6.8.13617

Source DB:  PubMed          Journal:  Autophagy        ISSN: 1554-8627            Impact factor:   16.016


  1 in total

1.  Early autophagic response in a novel knock-in model of Huntington disease.

Authors:  Mary Y Heng; Duy K Duong; Roger L Albin; Sara J Tallaksen-Greene; Jesse M Hunter; Mathieu J Lesort; Alex Osmand; Henry L Paulson; Peter J Detloff
Journal:  Hum Mol Genet       Date:  2010-07-08       Impact factor: 6.150

  1 in total
  15 in total

1.  Rapamycin prevents the mutant huntingtin-suppressed GLT-1 expression in cultured astrocytes.

Authors:  Lei-lei Chen; Jun-chao Wu; Lin-hui Wang; Jin Wang; Zheng-hong Qin; Marian Difiglia; Fang Lin
Journal:  Acta Pharmacol Sin       Date:  2012-01-23       Impact factor: 6.150

Review 2.  MicroRNAs involved in drug resistance of breast cancer by regulating autophagy.

Authors:  Nan Wen; Qing Lv; Zheng-Gui Du
Journal:  J Zhejiang Univ Sci B       Date:  2020 Sept.       Impact factor: 3.066

3.  HD CAG-correlated gene expression changes support a simple dominant gain of function.

Authors:  Jessie C Jacobsen; Gillian C Gregory; Juliana M Woda; Morgan N Thompson; Kathryn R Coser; Vidya Murthy; Isaac S Kohane; James F Gusella; Ihn Sik Seong; Marcy E MacDonald; Toshi Shioda; Jong-Min Lee
Journal:  Hum Mol Genet       Date:  2011-05-02       Impact factor: 6.150

4.  The ubiquitin conjugating enzyme Ube2W regulates solubility of the Huntington's disease protein, huntingtin.

Authors:  Bo Wang; Li Zeng; Sean A Merillat; Svetlana Fischer; Joseph Ochaba; Leslie M Thompson; Sami J Barmada; Kenneth M Scaglione; Henry L Paulson
Journal:  Neurobiol Dis       Date:  2017-10-03       Impact factor: 5.996

5.  Restoration of CTSD (cathepsin D) and lysosomal function in stroke is neuroprotective.

Authors:  M Iqbal Hossain; Joshua M Marcus; Jun Hee Lee; Patrick L Garcia; VinodKumar Singh; John J Shacka; Jianhua Zhang; Toby I Gropen; Charles N Falany; Shaida A Andrabi
Journal:  Autophagy       Date:  2020-05-25       Impact factor: 16.016

6.  Methylene blue induces macroautophagy through 5' adenosine monophosphate-activated protein kinase pathway to protect neurons from serum deprivation.

Authors:  Luokun Xie; Wenjun Li; Ali Winters; Fang Yuan; Kunlin Jin; Shaohua Yang
Journal:  Front Cell Neurosci       Date:  2013-05-03       Impact factor: 5.505

Review 7.  Targeting autophagy in neurodegenerative diseases: From molecular mechanisms to clinical therapeutics.

Authors:  Amir Ajoolabady; Hamid Aslkhodapasandhokmabad; Nils Henninger; Laurie J Demillard; Masoud Nikanfar; Alireza Nourazarian; Jun Ren
Journal:  Clin Exp Pharmacol Physiol       Date:  2021-04-21       Impact factor: 2.963

8.  Grb2 is regulated by foxd3 and has roles in preventing accumulation and aggregation of mutant huntingtin.

Authors:  Shounak Baksi; Nihar R Jana; Nitai Pada Bhattacharyya; Debashis Mukhopadhyay
Journal:  PLoS One       Date:  2013-10-08       Impact factor: 3.240

9.  A broad phenotypic screen identifies novel phenotypes driven by a single mutant allele in Huntington's disease CAG knock-in mice.

Authors:  Sabine M Hölter; Mary Stromberg; Marina Kovalenko; Lillian Garrett; Lisa Glasl; Edith Lopez; Jolene Guide; Alexander Götz; Wolfgang Hans; Lore Becker; Birgit Rathkolb; Jan Rozman; Anja Schrewed; Martin Klingenspor; Thomas Klopstock; Holger Schulz; Eckhard Wolf; Wolfgang Wursta; Tammy Gillis; Hiroko Wakimoto; Jonathan Seidman; Marcy E MacDonald; Susan Cotman; Valérie Gailus-Durner; Helmut Fuchs; Martin Hrabě de Angelis; Jong-Min Lee; Vanessa C Wheeler
Journal:  PLoS One       Date:  2013-11-22       Impact factor: 3.240

10.  Studies on the Q175 Knock-in Model of Huntington's Disease Using Functional Imaging in Awake Mice: Evidence of Olfactory Dysfunction.

Authors:  Craig F Ferris; Praveen Kulkarni; Steven Toddes; Jason Yee; William Kenkel; Mark Nedelman
Journal:  Front Neurol       Date:  2014-06-30       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.